GlaxoSmithKline Advances Sales Growth in Latin America with Acquisition of Laboratorios Phoenix
Heather Cartwright
Abstract
Following its strategy of expanding its business in emerging markets, GlaxoSmithKline has acquired Laboratorios Phoenix, an Argentinian producer of branded generics.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.